KRAS and neoplasm: This has been shown for the KRASG12D mutation in a patient with metastatic colorectal cancer,15 and we observed that repetitive exposure to autologous tumour cells can result in enrichment of KRAS-specific T cells that was non-detectable in the ‘young’ TILs population.